Early findings suggest some women with low-risk DCIS may avoid immediate surgery, although investigators caution that longer ...

Researchers using the gold-standard DEXA to measure body fat percentage showed that BMI misclassified a notable proportion of ...

Ontario will replace nine supervised consumption sites with HART hubs, but critics warn the lack of harm reduction could ...

New data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though ...

Switching to tirzepatide yields greater quality-of-life benefits than increasing the dulaglutide dose in patients with type 2 diabetes.

Recombinant zoster vaccine uptake in adults with rheumatic disease reached around 10% in the 20 months following the updated 2021 recommendations, with lack of tracking and education seen as barriers.

The proposed EU expansion would extend access to Besponsa, a CD22-directed therapy in children with relapse of acute lymphoblastic leukemia or in whom prior treatment has failed.

Current GLP-1 standards of care focus on once-weekly dosing, with doctor-recommended, supervised titration depending on ...

Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung ...

Early and continuous treatment with acoramidis is linked to lower risks for death and heart-related hospitalization than delayed treatment in patients with transthyretin amyloid cardiomyopathy.

Is protecting clinicians actually causing harm? Experts call for a rethinking of radiation safety that also tackles the ...

Dr Bradley Corr discusses what he’s most excited to hear at the SGO Annual Meeting, including new data on antibody-drug ...